Maxim Weinstein’s blog

• Clinical trials are critical to understanding diseases and effects of immunizations. [p. 95] How cool (albeit expensive) would it be if we could do clinical trials of new anti-malware software? I could imagine a third-party company enlisting a bunch of computer techs/consultants to install the software and then check back with the user and computer a few times to look for signs (observable evidence) and symptoms (user-reported evidence) of malware infection and “adverse events.” The hard part would be making it controlled and double blind, though having some sort of control (e.g., the free Microsoft protection or an older, established product) might be possible.

This entry is part of a series. See the introduction for more information.